Predicting relapse risk in childhood acute lymphoblastic leukaemia.
about
Current Strategies for the Detection of Minimal Residual Disease in Childhood Acute Lymphoblastic LeukemiaChildhood acute lymphoblastic leukemia: Integrating genomics into therapyAbsence of Association between CCR5 rs333 Polymorphism and Childhood Acute Lymphoblastic Leukemia.Increased post-induction intensification improves outcome in children and adolescents with a markedly elevated white blood cell count (≥200 × 10(9) /l) with T cell acute lymphoblastic leukaemia but not B cell disease: a report from the Children's OnGene Signature of High White Blood Cell Count in B-Precursor Acute Lymphoblastic LeukemiaAdvances in paediatric cancer treatmentMinimal Residual Disease Evaluation in Childhood Acute Lymphoblastic Leukemia: An Economic Analysis.Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation.Machine learning applications for prediction of relapse in childhood acute lymphoblastic leukemia.Pediatric T-cell acute lymphoblastic leukemia.Prognostic significance of P2RY8-CRLF2 and CRLF2 overexpression may vary across risk subgroups of childhood B-cell acute lymphoblastic leukemia.IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.Overexpression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in childhood acute lymphoblastic leukemia.Prevalence of gene rearrangements in Mexican children with acute lymphoblastic leukemia: a population study-report from the Mexican Interinstitutional Group for the identification of the causes of childhood leukemia.Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens.Whole-genome DNA methylation characteristics in pediatric precursor B cell acute lymphoblastic leukemia (BCP ALL).Skeletal abnormalities detected by SPECT is associated with increased relapse risk in pediatric acute lymphoblastic leukemia.Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse.Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypes.
P2860
Q26751269-69B8FD15-9544-4DF1-AE9B-32EA3B4CE4FAQ28080463-222C3514-9483-4DA9-B61C-F523F53D2ADEQ33562659-41BA372C-919E-49C9-86EA-995B9BC9E8B5Q35039727-765149C1-C8FC-4C00-9CFC-133CAC26915FQ36106554-F895377A-CC30-4FCC-886A-C8FA9FB1A807Q36508630-BE9D6E68-B264-4F78-B4F9-4850027C99CAQ36731638-15B69730-4C03-445C-A544-8BF073B6A72CQ37169331-EDA21993-1BC6-4C18-AEAD-4644960D60BDQ38434710-CD83DB75-6849-47D8-B785-5BC7624F92D4Q38636061-44E5C745-1836-4239-838F-ACAEDC80ED54Q38956273-7D472C2B-4E30-412D-810C-FCDA8BC1C201Q40537705-23C67516-DB1D-4315-AB0B-74B9128D341CQ41688725-8B7958C7-363B-4EA5-8730-33EEE6EC789FQ41752588-C0C63650-C533-4E67-8F88-2562B788E585Q41869513-88AEBCC4-A52E-434F-AE02-A8E82C8E212AQ45985775-23809403-6102-4887-BC97-B9664222CE30Q47097037-0629DD15-F812-49BE-A89F-ACE94AF3AA21Q47145140-397A6705-8BF5-40D1-8E97-5EE177707FFFQ50420858-B6ED075B-8CB8-40A6-A18C-D04246012993Q51711055-A1D99E0D-712D-4396-AE20-EBF98ED307B0
P2860
Predicting relapse risk in childhood acute lymphoblastic leukaemia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Predicting relapse risk in childhood acute lymphoblastic leukaemia.
@en
type
label
Predicting relapse risk in childhood acute lymphoblastic leukaemia.
@en
prefLabel
Predicting relapse risk in childhood acute lymphoblastic leukaemia.
@en
P2860
P356
P1476
Predicting relapse risk in childhood acute lymphoblastic leukaemia.
@en
P2093
David T Teachey
P2860
P304
P356
10.1111/BJH.12442
P407
P577
2013-06-29T00:00:00Z